Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.
Brian S WoodDakota J BatchekDavid H LynchHillary B SpanglerDanae C GrossCurtis Lee PetersenJohn A BatsisPublished in: Calcified tissue international (2023)
The potential lack of significant differences in weight loss or physical function between older adults with and without sarcopenic obesity participating in a weight loss intervention may suggest that well-designed, multicomponent interventions can lead to similar outcomes irrespective of sarcopenia status in persons with obesity. Fully powered randomized clinical trials are critically needed to confirm these preliminary results.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- randomized controlled trial
- glycemic control
- weight gain
- physical activity
- metabolic syndrome
- insulin resistance
- obese patients
- type diabetes
- community dwelling
- skeletal muscle
- clinical trial
- adipose tissue
- body mass index
- risk assessment
- middle aged